Tag Archives: TradingMarkets.com

YM BioSciences Releases 2Q Fiscal 2011 Operational and Financial Results – TradingMarkets.com

Posted on February 18, 2011 by admin

In addition to demonstrating positive efficacy signals in the approvable endpoints in this indication, splenomegaly and symptomatic improvement, CYT387 also exhibited a promising ability to positively impact anemia, a major life-shortening symptom … Bing News – Full Story →

Posted in Spleen Diseases | Tagged 2011, BioSciences, Financial, Fiscal, Operational, Releases, Results, TradingMarkets.com | Leave a comment

New Data Show That Subcutaneous Injection of an Investigational Formulation of ORENCIA(R) (abatacept … – TradingMarkets.com

Posted on November 14, 2010 by admin

Other events potentially associated with drug hypersensitivity, such as hypotension, urticaria and dyspnea, each occurred in less than 0.9% of patients treated with ORENCIA and generally occurred within 24 hours of infusion. There was one case of a … Bing … Continue reading →

Posted in Hives | Tagged abatacept, Data, Formulation, Injection, Investigational, ORENCIAR, show, Subcutaneous, TradingMarkets.com | Leave a comment

Absorption Systems Receives Qualifying Therapeutic Discovery Project Grant to Advance … – TradingMarkets.com

Posted on November 9, 2010 by admin

According to a release, the grant acknowledges the company’s CellPort Technologies and its ability to help develop safe and effective drug combinations for the treatment of diseases such as cancer, diabetes, hyperlipidemia and HIV. CellPort Technologies … Bing News – … Continue reading →

Posted in Cholesterol | Tagged Absorption, Advance, discovery, Grant, Project, Qualifying, Receives, Systems, Therapeutic, TradingMarkets.com | Leave a comment